Ironwood Pharmaceuticals, Inc. (IRWD)
4.18
-0.06
(-1.42%)
USD |
NASDAQ |
Aug 28, 10:14
Ironwood Pharmaceuticals Cash from Operations (Quarterly) : 58.28M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.28M |
| March 31, 2026 | 5.121M |
| December 31, 2025 | 74.58M |
| September 30, 2025 | 47.58M |
| June 30, 2025 | -15.07M |
| March 31, 2025 | 19.95M |
| December 31, 2024 | 15.21M |
| September 30, 2024 | 9.885M |
| June 30, 2024 | 33.46M |
| March 31, 2024 | 44.98M |
| December 31, 2023 | 35.83M |
| September 30, 2023 | 32.46M |
| June 30, 2023 | 34.96M |
| March 31, 2023 | 80.17M |
| December 31, 2022 | 79.18M |
| September 30, 2022 | 69.09M |
| June 30, 2022 | 61.36M |
| March 31, 2022 | 64.12M |
| December 31, 2021 | 64.57M |
| September 30, 2021 | 75.06M |
| June 30, 2021 | 48.57M |
| March 31, 2021 | 73.69M |
| December 31, 2020 | 51.51M |
| September 30, 2020 | 53.63M |
| June 30, 2020 | 20.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 43.60M |
| December 31, 2019 | 27.58M |
| September 30, 2019 | 34.77M |
| June 30, 2019 | -9.237M |
| March 31, 2019 | -42.38M |
| December 31, 2018 | 9.273M |
| September 30, 2018 | -26.58M |
| June 30, 2018 | -22.69M |
| March 31, 2018 | -30.89M |
| December 31, 2017 | -8.024M |
| September 30, 2017 | -31.24M |
| June 30, 2017 | -32.45M |
| March 31, 2017 | -27.85M |
| December 31, 2016 | -18.93M |
| September 30, 2016 | -0.145M |
| June 30, 2016 | -6.763M |
| March 31, 2016 | 0.161M |
| December 31, 2015 | -18.76M |
| September 30, 2015 | -26.23M |
| June 30, 2015 | -25.55M |
| March 31, 2015 | -35.78M |
| December 31, 2014 | -22.78M |
| September 30, 2014 | -38.68M |
| June 30, 2014 | -36.21M |
| March 31, 2014 | -57.89M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| AbbVie, Inc. | 3.436B |
| Rigel Pharmaceuticals, Inc. | 30.65M |
| Marker Therapeutics, Inc. | -3.716M |
| Verastem, Inc. | -43.91M |
| Theriva Biologics, Inc. | -3.085M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -199.70M |
| Free Cash Flow | 185.55M |
| Free Cash Flow Per Share (Quarterly) | 0.3486 |
| Free Cash Flow to Equity (Quarterly) | 258.77M |
| Free Cash Flow to Firm (Quarterly) | 63.29M |
| Free Cash Flow Yield | 26.34% |